Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter

Anliegen und Hintergrund

Die folgenden Empfehlungen richten sich an alle Berufsgruppen, die Kinder und Jugendliche mit Diabetes sowie deren Familien betreuen und unterstützen, sowie an übergeordnete Organisationen (z. B. Krankenkassen), die mit der Erkrankung befasst sind. Die Leitlinie konzentriert sich auf die Spezifika für diese Altersgruppe, die nicht oder davon abweichend in den allgemeinen Leitlinien zur Therapie des Typ-1-Diabetes der DDG dargestellt werden [1]. 

Entsprechend den Vorgaben der Gesundheits­minister der Länder und gängiger Praxis vieler Kliniken wird als Alter, bis zu dem die vorlie­gen­den pädiatrischen Leitlinien gelten sollen, das voll­endete 18. Lebensjahr definiert. Im klinischen Einzelfall können diese Leitlinien auch für das junge Erwachsenenalter herangezogen werden. 

Literatur

• 1 Scherbaum W A, Kerner W. Evidenzbasierte Leitlinie der DDG – Therapie des Diabetes mellitus Typ 1.  In: Martin S Dreyer M Kiess W Lüdecke H J Müller U A Schatz W Deutsche Diabetes Gesellschaft (DDG); 2007
• 2 Neu A, Willasch A, Ehehalt S et al. Prävalenz und Altersverteilung des Diabetes mellitus im Kindesalter in Deutschland.  Monatsschr Kinderheilkd. 2002;  150 196-200
• 3 Rosenbauer J, Icks A, Grabert M et al. Hohe Prävalenz des Typ-1-Diabetes mellitus im Kindes- und Jugendalter in Deutschland (Abstract).  Kinder-Jugendmed. 2002;  2
• 4 Ehehalt S, Blumenstock G, Willasch A M et al. Continuous rise in incidence of childhood Type 1 diabetes in Germany.  Diabet Med. 2008;  25 755-757
• 5 Neu A, Ehehalt S, Willasch A et al. Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age.  Diabetes Care. 2001;  24 785-786
• 6 Rosenbauer J, Icks A, Schmitter D et al. Incidence of childhood Type I diabetes mellitus is increasing at all ages in Germany.  Diabetologia. 2002;  45 457-458
• 7 Kurth B M, Schaffrath R A. Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland. Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KiGGS).  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;  50 736-743
• 8 Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den Body-Mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben.  Monatsschr Kinderheilkd. 2001;  149 807-818
• 9 Rosenbauer J, Icks A, du Prel J B et al. Populationsbasierte Daten zur Inzidenz des Typ-2-Diabetes mellitus bei Kindern und Jugendlichen in Deutschland.  Monatsschr Kinderheilkd. 2003;  151 71
• 10 Neu A, Feldhahn L, Ehehalt S et al. Prevalence of type 2 diabetes and MODY in children and adolescents. A state-wide study in Baden-Wuerttemberg (Germany).  Pediatr Diabetes. 2005;  6 27-28
• 11 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) .Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005 EK IV
• 12 Gale E A, Gillespie K M. Diabetes and gender.  Diabetologia. 2001;  44 3-15
• 13 Rosenbloom A L, Schatz D A, Krischer J P et al. Therapeutic controversy: prevention and treatment of diabetes in children.  J Clin Endocrinol Metab. 2000;  85 494-522
• 14 Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005 EK I b
• 15 Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA) .Leitlinien. Verabschiedet auf der Konsensus-Konferenz der AGA am 06.10.2008, Deutsche Adipositas-Gesellschaft; (2008)
• 16 Bangstad H J, Danne T, Deeb L C et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007.  Pediatr Diabetes. 2007;  8 88-102
• 17 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) .Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005 EK II b-III
• 18 Rewers M, Pihoker C, Donaghue K et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes.  Pediatr Diabetes. 2007;  8 408-418
• 19 Cranston I, Lomas J, Maran A et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.  Lancet. 1994;  344 283-287
• 20 Holl R W, Heinze E. Dawn- oder Somogyi-Phänomen? Hohe morgend­liche Nüchternblutzuckerwerte bei jugendlichen Typ-1-Diabetikern.  Dtsch Med Wochenschr. 1992;  117 1503-1507
• 21 Hellems M A, Clarke W L. Safe at school: a Virginia experience.  Diabetes Care. 2007;  30 1396-1398
• 22 American Diabetes Association (ADA) . Diabetes care in the school and day care setting.  Diabetes Care. 2007;  30 Suppl 1 S66-S73
• 23 Nakhla M, Daneman D, Frank M et al. Translating transition: a critical review of the diabetes literature.  J Pediatr Endocrinol Metab. 2008;  21 507-516
• 24 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) .Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005
• 25 Court J M, Cameron F J, Berg-Kelly K et al. Diabetes in adolescence.  ­Pediatr Diabetes. 2008;  9 255-262
• 26 Brink S, Laffel L, Likitmaskul S et al. Sick day management in children and adolescents with diabetes.  Pediatr Diabetes. 2007;  8 401-407
• 27 Diabetes Control and Complications Trial Research Group . The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.  Diabetes. 1995;  44 968-983
• 28 White N H, Sun W, Cleary P A et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.  Arch Ophthalmol. 2008;  126 1707-1715
• 29 Nathan D M, Cleary P A, Backlund J Y et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.  N Engl J Med. 2005;  353 2643-2653
• 30 Musen G, Jacobson A M, Ryan C M et al. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial.  Diabetes Care. 2008;  31 1933-1938
• 31 Bangstad H J, Danne T, Deeb L C et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007.  Pediatr Diabetes. 2007;  8 88-102
• 32 Danne T, Becker R H, Heise T et al. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.  Diabetes Care. 2005;  28 2100-2105
• 33 Mortensen H B, Lindholm A, Olsen B S et al. Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes.  Eur J Pediatr. 2000;  159 483-488
• 34 Deeb L C, Holcombe J H, Brunelle R et al. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.  Pediatrics. 2001;  108 1175-1179
• 35 Plank J, Siebenhofer A, Berghold A et al. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.  Arch Intern Med. 2005;  165 337-344
• 36 Simpson D, McCormack P L, Keating G M et al. Insulin lispro: a review of its use in the management of diabetes mellitus.  Drugs. 2007;  67 407-434
• 37 Danne T, Aman J, Schober E et al. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes.  Diabetes Care. 2003;  26 2359-2364
• 38 Danne T, Datz N, Endahl L et al. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial.  Pediatr Diabetes. 2008;  9 554-560
• 39 Thisted H, Johnsen S P, Rungby J. An update on the long-acting insulin analogue glargine.  Basic Clin Pharmacol Toxicol. 2006;  99 1-11
• 40 Robertson K J, Schoenle E, Gucev Z et al. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.  Diabet Med. 2007;  24 27-34
• 41 Phillip M, Battelino T, Rodriguez H et al. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European ­Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric ­Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes.  Diabetes Care. 2007;  30 1653-1662
• 42 Aslander-van Vliet E, Smart C et al. Nutritional management in childhood and adolescent diabetes.  Pediatr Diabetes. 2007;  8 323-339
• 43 Mann J, de Leeuw I, Hermansen K et al. Evidenz-basierte Ernährungsempfehlungen zur Behandlung und Prävention des Diabetes mellitus.  Diabet Stoffw. 2005;  14 75-94
• 44 Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungs­forschung (SGE), Schweizerische Vereinigung für Ernährung (SVE) .Referenzwerte für die Nährstoffzufuhr.. Neustadt / Weinstraße: Neuer Umschau Buchverl.; 2008
• 45 Bloomgarden Z T, Karmally W, Metzger M J et al. Randomized, controlled trial of diabetic patient education: improved knowledge without ­improved metabolic status.  Diabetes Care. 1987;  10 263-272
• 46 de Weerdt I, Visser A P, Kok G J et al. Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic ­patients: effects on metabolic control, quality of life, and costs of therapy.  Diabet Med. 1991;  8 338-345
• 47 Lange K, Sassmann H, von Schütz W et al. Prerequisites for age-appropriate education in type 1 diabetes: a model programme for paediatric diabetes education in Germany.  Pediatr Diabetes. 2007;  8 Suppl 6 63-71
• 48 Swift P G. Diabetes education. ISPAD clinical practice consensus guidelines 2006–2007.  Pediatr Diabetes. 2007;  8 103-109
• 49 Mensing C, Boucher J, Cypress M et al. National standards for diabetes self-management education. Task Force to Review and Revise the ­National Standards for Diabetes Self-Management Education Programs.  Diabetes Care. 2000;  23 682-689
• 50 Funnell M M, Brown T L, Childs B P et al. National standards for diabetes self-management education.  Diabetes Care. 2009;  32 Suppl 1 S87-S94
• 51 Bundesarbeitsgemeinschaft für Rehabilitation (BAR) .Gemeinsames Rahmenkonzept der Gesetzlichen Krankenkassen und der Gesetz­lichen Rentenversicherung für die Durchführung stationärer medi­zinischer Leistungen der Vorsorge und Rehabilitation für Kinder und Jugendliche. http://http://www.bar-frankfurt.de/upload/Rahmenkonzept.72dpi_435.pdf 2008
• 52 Fröhlich C, Hermann T, Koch S et al. Indikationen für eine stationäre ­Rehabilitation von Kindern und Jugendlichen mit Typ-1-Diabetes – eine bundesweite „DPV-Wiss“-Analyse.  Diabet Stoffw. 2008;  93
• 53 Verband Deutscher Rentenversicherungsträger (VDR) .Rahmenkonzept zur medizinischen Rehabilitation von Kindern und Jugendlichen in der gesetzlichen Rentenversicherung. Empfehlungen des Verbandes Deutscher Rentenversicherungsträger. http://http://infomed.mds-ev.de/sindbad.nsf/f79a8096ad98496fc12571e700442be0/3ccf1982457e68f080256bc4003b2fa3/$FILE/ATTS1QCV/VDR_KiJu-Reha_1998.pdf 1998
• 54 Deutsche Gesellschaft für pädiatrische Rehabilitation und Prävention .Leitlinie Rehabilitation Diabetes mellitus im Kindes- und Jugendalter. http://http://www.uni-duesseldorf.de/awmf/ll/070–003.htm 2007
• 55 Stachow R, Koch S, Fröhlich C et al. Effekte der stationären Rehabilitation von Kindern und Jugendlichen mit Diabetes mellitus Typ 1 – eine multizentrische DPV-Wiss-Analyse.  Diabet Stoffw. 2008;  59
• 56 Stachow R, Schultz A, Kurzinsky U et al. Anti-Streß-Training für Kinder und Jugendliche mit Diabetes während der stationären Rehabilitation.  Kindheit Entwicklung. 2001;  10 226-239
• 57 Delamater A M. Psychological care of children and adolescents with diabetes.  Pediatr Diabetes. 2007;  8 340-348
• 58 Forsander G, Persson B, Sundelin J et al. Metabolic control in children with insulin-dependent diabetes mellitus 5 y after diagnosis. Early detec­tion of patients at risk for poor metabolic control.  Acta Paediatr. 1998;  87 857-864
• 59 Hürter A, Otten A. Familien mit diabetischen Kindern und Jugendlichen: Psychische und soziale Probleme und der Wunsch nach psychologischer Hilfe im Vergleich mit anderen chronischen Erkrankungen.. In:, Roth R, Borkenstein M, , eds. Psychosoziale Aspekte in der Betreuung von Kindern und Jugendlichen mit Diabetes. Basel: Karger; 1991: 150-159
• 60 Sundelin J, Forsander G, Mattson S E. Family-oriented support at the onset of diabetes mellitus: a comparison of two group conditions during 2 years following diagnosis.  Acta Paediatr. 1996;  85 49-55
• 61 Delamater A M, Bubb J, Davis S G et al. Randomized prospective study of self-management training with newly diagnosed diabetic children.  Diabetes Care. 1990;  13 492-498
• 62 Rydall A C, Rodin G M, Olmsted M P et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus.  N Engl J Med. 1997;  336 1849-1854
• 63 Bryden K S, Neil A, Mayou R A et al. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.  Diabetes Care. 1999;  22 1956-1960
• 64 Nielsen S, Emborg C, Molbak A G. Mortality in concurrent type 1 diabetes and anorexia nervosa.  Diabetes Care. 2002;  25 309-312
• 65 Meltzer L J, Johnson S B, Prine J M et al. Disordered eating, body mass, and glycemic control in adolescents with type 1 diabetes.  Diabetes Care. 2001;  24 678-682
• 66 Colton P, Olmsted M, Daneman D et al. Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study.  Diabetes Care. 2004;  27 1654-1659
• 67 Liss D S, Waller D A, Kennard B D et al. Psychiatric illness and family ­support in children and adolescents with diabetic ketoacidosis: a controlled study.  J Am Acad Child Adolesc Psychiatry. 1998;  37 536-544
• 68 Northam E A, Matthews L K, Anderson P J et al. Psychiatric morbidity and health outcome in Type 1 diabetes – perspectives from a prospective longitudinal study.  Diabet Med. 2005;  22 152-157
• 69 Hood K K, Huestis S, Maher A et al. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics.  Diabetes Care. 2006;  29 1389-1391
• 70 Stewart S M, Rao U, Emslie G J et al. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus.  Pediatrics. 2005;  115 1315-1319
• 71 Lawrence J M, Standiford D A, Loots B et al. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study.  Pediatrics. 2006;  117 1348-1358
• 72 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) .Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005 EK III / IV
• 73 Glaser N S, Wootton-Gorges S L, Buonocore M H et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis.  Pediatr Diabetes. 2006;  7 75-80
• 74 Fiordalisi I, Novotny W E, Holbert D et al. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment.  Pediatr Diabetes. 2007;  8 142-149
• 75 Wolfsdorf J, Craig M E, Daneman D et al. Diabetic ketoacidosis.  Pediatr Diabetes. 2007;  8 28-43
• 76 Edge J A, Jakes R W, Roy Y et al. The UK case-control study of cerebral ­oedema complicating diabetic ketoacidosis in children.  Diabetologia. 2006;  49 2002-2009
• 77 Wolfsdorf J, Craig M E, Daneman D et al. Diabetic ketoacidosis.  Pediatr Diabetes. 2007;  8 28-43
• 78 Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral ­oedema in Sweden – a 2-year paediatric population study.  Diabet Med. 2007;  24 1080-1085
• 79 Roberts M D, Slover R H, Chase H P. Diabetic ketoacidosis with intracerebral complications.  Pediatr Diabetes. 2001;  2 109-114
• 80 Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus.  Pediatrics. 1982;  69 87-90
• 81 Banks C J, Furyk J S. Review article: hypertonic saline use in the emergency department.  Emerg Med Australas. 2008;  20 294-305
• 82 Clarke W, Jones T, Rewers A et al. Assessment and management of hypoglycemia in children and adolescents with diabetes.  Pediatr Diabetes. 2008;  9 165-174
• 83 Diabetes Control and Complications Trial Research Group . Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial.  J Pediatr. 1994;  125 177-188
• 84 Bangstad H J, Danne T, Deeb L C et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007.  Pediatr Diabetes. 2007;  8 88-102
• 85 Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association.  Diabetes Care. 2005;  28 186-212
• 86 Hill I D, Dirks M H, Liptak G S et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.  J Pediatr Gastroenterol Nutr. 2005;  40 1-19
• 87 Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association.  Diabetes Care. 2005;  28 186-212
• 88 Kordonouri O, Maguire A M, Knip M et al. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Other complications and associated conditions.  Pediatr Diabetes. 2007;  8 171-176
• 89 Hansen D, Brock-Jacobsen B, Lund E et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up.  Diabetes Care. 2006;  29 2452-2456
• 90 Amin R, Murphy N, Edge J et al. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease.  Diabetes Care. 2002;  25 1117-1122
• 91 Lewis H M, Renaula T L, Garioch J J et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis.  Br J Dermatol. 1996;  135 363-367
• 92 Genuth S, Alberti K G, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus.  Diabetes Care. 2003;  26 3160-3167
• 93 Alberti G, Zimmet P, Shaw J et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.  Diabetes Care. 2004;  27 1798-1811
• 94 UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.  Lancet. 1998;  352 837-853
• 95 Holman R R, Paul S K, Bethel M A et al. 10-year follow-up of intensive glucose control in type 2 diabetes.  N Engl J Med. 2008;  359 1577-1589
• 96 Shimazaki T, Kadowaki T, Ohyama Y et al. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital.  Transl Res. 2007;  149 196-204
• 97 UK Prospective Diabetes Study (UKPDS) Group . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.  Lancet. 1998;  352 854-865
• 98 Jones K L, Arslanian S, Peterokova V A et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial.  Diabetes Care. 2002;  25 89-94
• 99 Gottschalk M, Danne T, Vlajnic A et al. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study.  Diabetes Care. 2007;  30 790-794
• 100 Ellard S, Bellanne-Chantelot C, Hattersley A T. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.  Diabetologia. 2008;  51 546-553
• 101 Badenhoop K, Kordonouri O, Machicao F. Empfehlungen zur molekulargenetischen Diagnostik bei Verdacht auf MODY. DDG; 2008
• 102 Hattersley A, Bruining J, Shield J et al. ISPAD Clinical Practice Consensus Guidelines 2006–2007. The diagnosis and management of monogenic diabetes in children.  Pediatr Diabetes. 2006;  7 352-360
• 103 Flanagan S E, Edghill E L, Gloyn A L et al. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.  Diabetologia. 2006;  49 1190-1197
• 104 Babenko A P, Polak M, Cave H et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.  N Engl J Med. 2006;  355 456-466
• 105 Klupa T, Kowalska I, Wyka K et al. Mutations in the ABCC8 gene are associated with a variable clinical phenotype.  Clin Endocrinol (Oxf). 2008; 
• 106 Lanng S, Thorsteinsson B, Lund-Andersen C et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications.  Acta Paediatr. 1994;  83 72-77
• 107 Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus.  Acta Paediatr. 2001;  90 515-519
• 108 Rolon M A, Benali K, Munck A et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.  Acta Paediatr. 2001;  90 860-867
• 109 Dobson L, Hattersley A T, Tiley S et al. Clinical improvement in cystic ­fibrosis with early insulin treatment.  Arch Dis Child. 2002;  87 430-431
• 110 O'Riordan S M, Robinson P D, Donaghue K C et al. Management of cystic fibrosis-related diabetes.  Pediatr Diabetes. 2008;  9 338-344
• 111 de Man S A, Andre J L, Bachmann H et al. Blood pressure in childhood: pooled findings of six European studies.  J Hypertens. 1991;  9 109-114 b